“Arcadia are working on a new formulation which is not in a liquid form (freeze dried or similar).. it is hoped that this will address the GI issues, which we could all expect to improve discontinuation and maybe allow some who had had to discontinue to restart Daybue.”
I was unaware of that Sawvic.
Will they have to run trials to get a new formulation approved?
What timeline would that likely take? If you know.
thx
Ann: Comment on research report, page-181
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |